US 11,911,041 B2
Embolic compositions
Aaron Baldwin, Aliso Viejo, CA (US); Ami Mehta, Aliso Viejo, CA (US); and Jonathan Lam, Aliso Viejo, CA (US)
Assigned to MicroVention, Inc., Aliso Viejo, CA (US)
Filed by MicroVention, Inc., Aliso Viejo, CA (US)
Filed on Jul. 2, 2021, as Appl. No. 17/366,620.
Application 17/366,620 is a division of application No. 16/442,869, filed on Jun. 17, 2019, granted, now 11,051,826.
Application 16/442,869 is a continuation of application No. 15/687,263, filed on Aug. 25, 2017, granted, now 10,368,874, issued on Aug. 6, 2019.
Claims priority of provisional application 62/380,317, filed on Aug. 26, 2016.
Prior Publication US 2021/0330334 A1, Oct. 28, 2021
Int. Cl. A61B 17/12 (2006.01); C08F 20/26 (2006.01); A61K 31/785 (2006.01); A61K 49/04 (2006.01); C08L 33/14 (2006.01); A61B 17/00 (2006.01); A61B 90/00 (2016.01)
CPC A61B 17/12181 (2013.01) [A61B 17/12186 (2013.01); A61K 31/785 (2013.01); A61K 49/0438 (2013.01); A61K 49/0442 (2013.01); C08F 20/26 (2013.01); A61B 2017/00938 (2013.01); A61B 2017/00942 (2013.01); A61B 2090/3933 (2016.02); A61B 2090/3966 (2016.02); C08L 33/14 (2013.01)] 20 Claims
 
1. A method of delivering a composition comprising:
injecting a composition, including a biocompatible polymer, a solvent, and a visualization agent, through a delivery device into a location with physiological conditions, wherein the biocompatible polymer is soluble in the solvent and insoluble at physiological conditions, and wherein the composition has a viscosity of less than about 15 centistokes.